Kaiser Permanente Showcases AI & Machine Learning in Health Care
TL/DR –
The Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center of Kaiser Permanente has awarded five healthcare organizations funding for research projects. These projects aim to enhance healthcare diagnostic decision-making through the use of artificial intelligence (AI) and machine learning (ML). The grants of up to $750,000 have been funded by the Gordon and Betty Moore Foundation in support of AI and ML application in various healthcare settings and diverse patient groups.
5 Health Care Organizations Secure Funding to Evaluate AI-enhancements in Patient Care
Five healthcare organizations have been granted funding by the Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center to conduct research into the application of artificial intelligence (AI) and machine learning (ML) for improved diagnostic decision-making.
AIM-HI, a program of the Kaiser Permanente Northern California Division of Research (DOR), leads a nationwide research initiative to extensively evaluate AI and ML in healthcare. Successful applicants receive grants up to $750,000, courtesy of the Gordon and Betty Moore Foundation, to showcase the effectiveness of AI and ML in diverse, real-world scenarios.
Around 120 applications were received, reflecting an expansive range of AI and ML applications in healthcare such as predictive models, computer vision, and large language models. Kaiser Permanente, as the initiative’s sponsor, did not qualify for the funding.
Vincent Liu, MD, the principal investigator of AIM-HI, said, “Choosing from numerous innovative and impactful projects was a challenge. We selected a balanced portfolio addressing real-world issues across diverse technologies, healthcare settings, and patient categories.”
Grant Recipients
These include:
- Cesar Termulo, Jr., MD (Parkland Health) for AI/ML Model in Pediatric Asthma Management
- David Ouyang, MD (Smidt Heart Institute at Cedars-Sinai Medical Center) for Cardiac Amyloidosis Identification
- Sivasubramanium Bhavani, MD, MS (Emory University) for the PRECISE trial
- Fatima Munoz, MD, MPH (San Ysidro Health) for Diabetic Retinopathy Screening AI
- Peter J. Embí, MD, MS (Vanderbilt University Medical Center) for Advancing Novel Approaches for AI-Enabled Diagnosis
The AIM-HI Coordinating Center and AIM-HI Advisory Committee will support grantees throughout the project’s three-year duration, sharing best practices and promoting AI and ML use in healthcare.
Stephen M. Parodi, MD, EVP of The Permanente Federation and The Permanente Medical Group, said, “All 5 projects can significantly improve patient outcomes with responsible use of cutting-edge AI technologies.” Maria Ansari, MD, FACC, CEO of The Permanente Medical Group, added, “Supporting health care organizations as they evaluate AI and ML in their unique settings fulfills our vision and commitment to clinicians, patients, and communities.”
About Kaiser Permanente Division of Research
The Kaiser Permanente Division of Research aims to enhance the health and medical care of KP members and society. Working on over 450 projects, the 600+ staff focus on understanding illness and well-being determinants and improving health care quality and cost-effectiveness. Follow us @KPDOR.
—
Read More Health & Wellness News ; US News